The Potential of Repetitive Transcranial Magnetic Stimulation for Autism Spectrum Disorder: A Consensus Statement

Autism spectrum disorder (ASD) affects approximately 1 in 59 children, but there are currently no biomedical treatments available that target the core symptoms (1). Preliminary evidence suggests that repetitive transcranial magnetic stimulation (rTMS) may have the potential to alleviate difficulties experienced by individuals with ASD (2). The evidence supporting the use of rTMS for ASD has led researchers in the field to form a consensus group that has met annually since 2014. Here we summarize discussions from the most recent meeting in May 2017, including recommendations for future research directions.

Source: Biological Psychiatry - August 11, 2018 Category: Psychiatry Authors: Eleanor J. Cole, Peter G. Enticott, Lindsay M. Oberman, M. Frampton Gwynette, Manuel F. Casanova, Scott L.J. Jackson, Ali Jannati, James C. McPartland, Adam J. Naples, Nicolaas A.J. Puts, rTMS in ASD Consensus Group Tags: Correspondence Source Type: research